Stocks · Health care · Biological Products, (No Diagnostic Substances)

Denali Therapeutics Inc.

DNLI Clue Score33
United States Fiscal year ends December CIK 0001714899 Results filed 3 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Nancy Thornberry
2 Sep 2026
Director
Sold on a plan
615
$23.74
$14.60K
Nancy Thornberry
2 Sep 2026
Director
Sold on a plan
10,824
$22.85
$247.33K
Alexander O. Schuth
1 Sep 2026
COFO and Secretary
Sold on a plan
2,768
$23.44
$64.88K

What was left out

Form 4 filings counted 18
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 0
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 226,552
History held since 8 Dec 2017